Raymond: No point buying him out. The cap saving in '16-17 would be offset by the buyout cap hit in '17-18, compared to just burying him in the AHL.
Smid: I consider it unlikely he'll be medically cleared to play. From what I hear, he may just wind up on LTIR until his contract is up, and then retire. In that case, he isn't taking up a roster spot and his cap hit is immaterial.
Stajan: Overpaid for what he brings, but I hate the thought of paying a buyout for four more years. Would rather trade him with 50% retained, even for a bag of pucks, and get the pain over with sooner.
Engelland: Brings something to the team that nobody else does. Yes, he's overpaid, but one more year of his contract isn't going to prevent any necessary moves.
Wideman, I think, is the best buyout candidate of the lot. I suspect he torpedoed whatever trade value he had with his disastrous finish to the season. If Treliving couldn't find a taker after his 56-point season, as reported, his value must be negative now. NTC means burying him is not an option, so a buyout would be the only way to save any part of his cap hit.
__________________
WARNING: The preceding message may not have been processed in a sarcasm-free facility.
|